SocialWellth has geared up to take its approach of offering private, healthcare-focused app stores to health systems – moving beyond its current customer base of insurance companies and self-insured employers, according to a company source.
The company has raised $7.5 million from a yet-to-be disclosed investor.
It will also use that money to increase its digital health research and development and integrate Happtique,the app certification business it acquired last year.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
SocialWellth, led by David Vinson, developed an mHealth dashboard to integrate and aggregate third-party apps and devices to help payer members manage their activities in one location and help them manage their health. The goal is for payers to enhance member engagement by offering incentives, coaching, and personalized recommendations. It also assesses mobile health apps on behalf of healthcare sponsors.
Since December it has begun curating apps for chronic conditions as part of a population health management channel bWell.
It has curated more than 300 mobile health apps and devices, according to its website. Through its API management services it has curated more than 700 APIs to help payers configure personalized components for their members.
In an interview in December, Vinson told MedCity News that acquiring Happtique was a precursor to investment across multiple sectors including prescriptive digital health plans with providers and payers.
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
In the past several months other groups have shown interest in providing mobile health tools to their customers through app stores they cultivate. Morristown Medical Center, part of the Atlantic Health System, opened a storefront in its lobby modeled on the Apple Genius Bar as part of a series of initiatives to help patients better utilize health apps.
